Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)
National Institutes of Health · Department of Health and Human Services
At a glance
Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed) is a forecasted federal cooperative agreement opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of October 7, 2026; forecast dates can change. Individual awards are listed as up to $700K, with about 4 awards expected. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.279 (Drug Use and Addiction Research Programs).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Sep 11, 2025Forecast posted
- Jul 1, 2026 (est.)Full notice expected
- Oct 7, 2026 (est.)Application deadline
- Jul 1, 2027 (est.)Est. award datenext date
- Posted
- Sep 11, 2025
- Est. close date
- Oct 7, 2026
- Est. award date
- Jul 1, 2027
- Award floor
- Not specified
- Award ceiling
- $700,000
- Est. total funding
- Not specified
- Expected awards
- 4
- Cost sharing
- Not required
- Funding instrument
- Cooperative Agreement
- Opportunity category
- Discretionary
- Fiscal year
- FY2027
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The National Institute on Drug Abuse (NIDA) seeks to advance its mission by supporting the expansion of the Collaboratory on Neural Ensembles & Used Substances (NExUS), an effort to build a knowledgebase of the neural cell populations and computations altered by substance-associated experiences, and underlying neurobehavioral states characteristic of addiction, or protective against it. This notice is provided to allow prospective applicants to develop applications that achieve the following goals:
1) Collect and share granular datasets descriptive of neural cell populations tuned to tractable features of substance-related experiences
2) Integrate cell-resolved readouts of ensemble activity with other granular data modalities (e.g., molecular cell identity, epigenetic state, morphology, spatial localization or connectivity)
3) Develop tools for analysis and visualization of ensemble composition and geometry, and document their scalability
4) Inform and test models for the mechanisms whereby cells or motifs are recruited into coding ensembles
5) Enable synergies among NExUS-funded projects and with other cell atlasing efforts through coordination of outreach, data standards, analytics, common spatial frameworks, and reference taxonomies
Grant Authorities that allow NIDA to forecast this opportunity are as follows: Section 301 (42 U.S.C. § 241) and Section 405 (42 U.S.C. § 284).
How to apply
0 of 8 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 93.279
Historical data · not a predictionAgency contact (as published)
Integrative Neuroscience Branch Program Staff
INBranch_NIDA@nih.gov
Please contact via e-mail
Changes we detected
- Oct 9, 2026: Close date changed
- Oct 9, 2026: Title changed
Quick answers
Is this opportunity open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around July 1, 2026. Forecast details and dates can change.
Who is eligible to apply for this opportunity?
The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.
How much funding is available through this opportunity?
Per the notice, individual awards are listed as up to $700k and the agency expects to make about 4 awards.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-DA-28-013), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Dec 3, 2026
- Who can apply
- Others (see notice)
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Feb 8, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Up to $700K
- Closes
- Feb 11, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Feb 11, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
National Institutes of Health- Award range
- Up to $1.5M
- Closes
- Mar 5, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
National Institutes of Health- Award range
- Amount not specified
- Closes
- Mar 6, 2027
- Who can apply
- State governments, County governments, City or township governments and 12 more